Company / Goodwill
Pacira BioSciences, Inc. Goodwill History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Goodwill
$20.2M
FY2025
5-year range
$0 / $163.2M
FY2021-FY2025
Trend
-
vs FY2024
Sector context
#53 of 75
Health Care
What the data says
At $20M, Pacira BioSciences, Inc.'s goodwill ranks #53 of 75 in the Health Care sector. Declined from $163M to $20M over the past 2 years.
Based on SEC 10-K filings.
$20M in FY2025 with a 5-year CAGR of -27.3%.
Declined from $163M to $20M over the past 2 years.
Health Care sector context is included.
Goodwill over time
Growth rates
- 3-Year CAGR
- -50.2%
- 5-Year CAGR
- -27.3%
- 10-Year CAGR
- -
Sector benchmark
#53 of 75 in Health CareTop 71% of 75This company $20.2M Sector average $4.0B
▼
-99.5% below sector average
Key checks
Key Insights
- 5-year CAGR of -27.3%, indicating a declining trend.
- Ranks #53 out of 75 companies in the Health Care sector.
- Peak goodwill was recorded in FY2023.
- Lowest goodwill in the period was in FY2024.
Company context
Key Data Points
- High Piotroski F-Score: 8/9 (strong financial health signals)
- Negative profit margin: -14.8%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | GoodwillValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $20.2M | - |
| FY2024 | $0 | -100.0% |
| FY2023 | $163.2M | +0.0% |
| FY2022 | $163.2M | +64.0% |
| FY2021 | $99.5M | +0.0% |
| FY2020 | $99.5M | +60.5% |
| FY2019 | $62.0M | +12.4% |
| FY2018 | $55.2M | +18.1% |
| FY2017 | $46.7M | +0.0% |
| FY2016 | $46.7M | +51.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026